Drugs / GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV
last change Nov 2001 re-read 3 minutes ago

GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV

Cell therapy

Developed for
hematopoietic and lymphoid cell neoplasm · HIV infectious disease
Investigated by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Trials 1

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00005785 Sep 1999 → Nov 2001 HIV infectious disease, hematopoietic and lymphoid cell neoplasm National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00005785 ↗
Action Inhibit “designed to obstruct HIV reproduction” NCT00005785 ↗
Modality Cell therapy “transplanting stem cells instead of bone marrow” NCT00005785 ↗
Route Intravenous “The thawed stem cells will then be infused through a vein.” NCT00005785 ↗